参考文献/References:
[1]. Deisseroth K.Optogenetics[J].Nat Methods,2011,8(1):26-29.
[2]. Karathanos TV,Boyle PM,Trayanova NA.Light-based approaches to cardiac arrhythmia research: from basic science to translational applications[J].Clin Med Insights Cardiol,2016,10(suppl 1):47-60.
[3]. Nagel G,Szellas T,Huhn W,et al.Channelrhodopsin-2,a directly light-gated cation-selective membrane channel[J].Proc Natl Acad Sci U S A,2003,100(24):13940-13945.
[4]. Avula UMR,Yoon HK,Lee CH,et al.Cell-selective arrhythmia ablation for photomodulation of heart rhythm[J].Sci Transl Med,2015,7(311):311ra172.
[5]. Calkins H,Kuck KH,Cappato R,et al.2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design[J].Europace,2012,14(4):528-606.
[6]. Peralvarez-Marin A,Garriga P.Optogenetics comes of age: novel inhibitory light-gated anionic channels allow efficient silencing of neural function[J].Chembiochem,2016,17(3):204-206.
[7]. Lin SC,Deisseroth K,Henderson JM.Optogenetics:background and concepts for neurosurgery[J].Neurosurgery,2011,69(1):1-3.
[8]. Entcheva E,Bub G.All-optical control of cardiac excitation:combined high-resolution optogenetic actuation and optical mapping[J].J Physiol,2016,594(9):2503-2510.
[9]. Nussinovitch U,Gepstein L.Optogenetics for in vivo cardiac pacing and resynchronization therapies[J].Nat Biotechnol,2015,33:750-754.
[10]. Bruegmann T,Boyle PM,Vogt CC,et al.Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations[J].J Clin Invest,2016,126(10):3894-3904.
[11]. Arrenberg AB,Stainier DY,Baier H,et al.Optogenetic control of cardiac function [J]. Science,2010,330(6006):971-974.
[12]. Crocini C,Ferrantini C,Coppini R,et al.Optogenetics design of mechanistically based stimulation patterns for cardiac defibrillation [J].Sci Rep,2016,6:35628.
[13]. Herron TJ,Lee P,Jalife J.Optical imaging of voltage and calcium in cardiac cells & tissues[J].Circ Res,2012,110(4):609-623.
[14]. Nyns EC,Kip A,Bart CI,et al.Optogenetic termination of ventricular arrhythmias in the whole heart:towards biological cardiac rhythm management[J].Eur Heart J,2017,38(27):2132-2136.
[15]. Wang Y,Lin WK,Crawford W,et al.Optogenetic control of heart rhythm by selective stimulation of cardiomyocytes derived from Pnmt＋ cells in murine heart[J].Sci Rep,2017,7:40687.
[16]. Chen PS,Chen LS,Fishbein MC,et al.Role of the autonomic nervous system in atrial fibrillation:pathophysiology and therapy[J].Circ Res,2014,114(9):1500-1515.
[17]. Wengrowski AM,Wang X,Tapa S,et al.Optogenetic release of norepinephrine from cardiac sympathetic neurons alters mechanical and electrical function[J].Cardiovasc Res,2015,105(2):143-150.
[18]. 周明敏,刘育.心-心交感神经反射与室性心律失常[J].中国心脏起搏与心电生理杂志,2019,33(1):59-62.
[19]. Yu L,Zhou L,Cao G,et al.Optogenetic modulation of cardiac sympathetic nerve activity to prevent ventricular arrhythmias[J].J Am Coll Cardiol,2017,70(22):2778-2790.
[20]. 武汉大学.一种基于光遗传学的无线神经调控装置:CN201710113614.4[P].2017-06-20.
[21]. 郭潇雅.用蓝牙连接生命[J].中国医院院长,2017,补充卷？(10):32-33.
[22]. Zaglia T,Pianca N,Borile G,et al.Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2[J].Proc Natl Acad Sci U S A,2015,112(32):E4495-E4504.
[23]. Dobrzynski H,Anderson RH,Atkinson A,et al.Structure,function and clinical relevance of the cardiac conduction system,including the atrioventricular ring and outflow tract tissues[J].Pharmacol Ther,2013,139(2):260-288.
[24]. Burton RA,Klimas A,Ambrosi CM,et al.Optical control of excitation waves in cardiac tissue[J]. Nat Photonics,2015,9(12):813-816.
[25]. Vogt CC,Bruegmann T,Malan D,et al.Systemic gene transfer enables optogenetic pacing of mouse hearts[J].Cardiovasc Res,2015,106(2):338-343.
[26]. Scardigli M,Müllenbroich C,Margoni E,et al.Real-time optical manipulation of cardiac conduction in intact hearts[J].J Physiol,2018,596(17):3841-3858．
[27]. Nyns ECA,Kip A,Bart CI,et al.Optogenetic termination of ventricular arrhythmias in the whole heart:towards biological cardiac rhythm management[J].Eur Heart J,2017,38(27):2132-2136.
[28]. Karathanos TV,Bayer JD,Wang D,et al.Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study[J].J Physiol,2016,594(23):6879-6891.
[29]. 王燕,许纲,程立君,等.心房纤维化研究进展[J].心血管病学进展,2019,40(3):389-392.
[30]. Boyle PM,Murphy MJ,Karathanos TV,et al.Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting:insights from computational models[J].J Physiol,2018,596(2):181-196．
[31]. Bingen BO,Engels MC,Schalij MJ,et al.Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes[J].Cardiovasc Res,2014,104(1):194-205.
[32]. 郭轩彤,张春波.光遗传学技术研究进展[J].中国生物工程杂志,2019,39(3):87-96.
[33]. 王晞,来欣.光遗传学技术与光起搏——心电生理研究中的新手段[J].中国心脏起搏与心电生理杂志,2014,28(4):283-285.
相似文献/References:
[1]赵靖华,综述,尚美生,等.衰老与心律失常[J].心血管病学进展,2016,(2):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
ZHAO Jinghua,SHANG Meisheng,YAO Yan.Aging and Arrhythmias[J].Advances in Cardiovascular Diseases,2016,(7):121.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.006]
[2]娄奇,李为民.CaV1.2在心律失常中作用的研究进展[J].心血管病学进展,2019,(6):919.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.020]
LOU Qi,LI Weimin.CaV1.2 in Arrhythmias[J].Advances in Cardiovascular Diseases,2019,(7):919.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.020]
[3]李如意 刘延俊 杜荣品.心力衰竭时β3-肾上腺素能受体与心律失常的研究进展[J].心血管病学进展,2020,(1):51.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.014]
LI Ruyi,LIU Yanjun,DU Rongpin.β3-adrenergic Receptors and Arrhythmia in Heart Failure[J].Advances in Cardiovascular Diseases,2020,(7):51.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.014]
[4]程家元 殷跃辉.沙库巴曲缬沙坦在心血管疾病中的临床应用与展望[J].心血管病学进展,2020,(9):914.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.007]
CHENG Jiayuan YIN Yuehui.Clinical Application and Prospect of Sacubitril Valsartan in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(7):914.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.007]
[5]查克岚 叶强.心电图成像在心律失常诊治中的研究进展[J].心血管病学进展,2020,(9):930.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.011]
ZHA Kelan,YE Qiang.Electrocardiographic Imaging in Arrhythmia Diagnosis and Treatment[J].Advances in Cardiovascular Diseases,2020,(7):930.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.011]
[6]袁佳栎 王群山.人工智能在心律失常诊断中的前景与挑战[J].心血管病学进展,2020,(10):999.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.001]
YUAN JialiWANG Qunshan.Prospects and Challenges of Arrhythmia Diagnosis by Artificial Intelligence[J].Advances in Cardiovascular Diseases,2020,(7):999.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.001]
[7]林晶 吉庆伟 刘伶.致心律失常性心肌病的研究进展[J].心血管病学进展,2020,(12):1247.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.006]
LING JingJI Qingwei,LIU Lin.Arrhythmogenic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(7):1247.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.006]
[8]李翠兰 刘文玲 高元丰.先天性与获得性长QT综合征诊断治疗现状[J].心血管病学进展,2021,(5):385.[doi:10.16806/j.cnki.issn.1004-3934.2021.0.001]
LI Cuilan,LIU Wenling,GAO Yuanfeng.Diagnostic and Therapeutic Status for Congenital and Acquired Long QT Syndrome[J].Advances in Cardiovascular Diseases,2021,(7):385.[doi:10.16806/j.cnki.issn.1004-3934.2021.0.001]
[9]崔利军 王永德.脉冲电场用于心律失常消融的研究进展[J].心血管病学进展,2022,(1):10.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.003]
CUI Lijun,WANG Yongde.Pulsed Electric Field for Ablation of Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(7):10.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.003]
[10]黄勇淇 田龙海 杨龙.室性期前收缩心肌病[J].心血管病学进展,2022,(4):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]
HUANG Yongqi,TIAN Longhai,YANG Long.Premature Ventricular Complexes Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(7):348.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.015]